194 related articles for article (PubMed ID: 36206229)
1. Expression profile of serum LncRNA THRIL and MiR-125b in inflammatory bowel disease.
Elamir A; Shaker O; Kamal M; Khalefa A; Abdelwahed M; Abd El Reheem F; Ahmed T; Hassan E; Ayoub S
PLoS One; 2022; 17(10):e0275267. PubMed ID: 36206229
[TBL] [Abstract][Full Text] [Related]
2. miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis.
Coskun M; Bjerrum JT; Seidelin JB; Troelsen JT; Olsen J; Nielsen OH
World J Gastroenterol; 2013 Jul; 19(27):4289-99. PubMed ID: 23885139
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location.
Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA
Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427
[TBL] [Abstract][Full Text] [Related]
4. Inter-correlation of lncRNA THRIL with microRNA-34a and microRNA-125b and their relationship with childhood asthma risk, severity, and inflammation.
Wang X; Li W; Sun S; An H
Allergol Immunopathol (Madr); 2023; 51(1):187-194. PubMed ID: 36617839
[TBL] [Abstract][Full Text] [Related]
5. Plasma Extracellular Vesicle LncRNA H19 as a Potential Diagnostic Biomarker for Inflammatory Bowel Diseases.
Heydari R; Fayazzadeh S; Shahrokh S; Shekari F; Farsad F; Meyfour A
Inflamm Bowel Dis; 2024 May; 30(5):795-807. PubMed ID: 37855715
[TBL] [Abstract][Full Text] [Related]
6. Serum long noncoding RNA H19/micro RNA-675-5p axis as a probable diagnostic biomarker in inflammatory bowel disease.
Shaker OG; Safa A; Khairy A; Abozeid NF
Mol Biol Rep; 2023 Nov; 50(11):9029-9036. PubMed ID: 37716920
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
8. Tissue and serum miR-149-3p/5p in hospitalized patients with inflammatory bowel disease: Correlation with disease severity and inflammatory markers.
Luo S; Chen XH
Kaohsiung J Med Sci; 2024 Feb; 40(2):131-138. PubMed ID: 37997516
[TBL] [Abstract][Full Text] [Related]
9. LINC00641/miR-378a and Their Cross-Talk with TNF-α/IFN-γ as Potential Biomarkers in Ulcerative Colitis and Crohn's Diseases.
Hameed NAA; Shaker OG; Hasona NA
J Interferon Cytokine Res; 2023 Nov; 43(11):531-537. PubMed ID: 37956249
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA THRIL promotes LPS-induced inflammatory injury by down-regulating microRNA-125b in ATDC5 cells.
Liu G; Wang Y; Zhang M; Zhang Q
Int Immunopharmacol; 2019 Jan; 66():354-361. PubMed ID: 30521964
[TBL] [Abstract][Full Text] [Related]
11. Elevated miRNA Inversely Correlates with
Guz M; Dworzański T; Jeleniewicz W; Cybulski M; Kozicka J; Stepulak A; Celiński K
Biomed Res Int; 2020; 2020():4250329. PubMed ID: 32775420
[TBL] [Abstract][Full Text] [Related]
12. Short noncoding RNAs as predictive biomarkers for the development from inflammatory bowel disease unclassified to Crohn's disease or ulcerative colitis.
James JP; Riis LB; Søkilde R; Malham M; Høgdall E; Langholz E; Nielsen BS
PLoS One; 2024; 19(2):e0297353. PubMed ID: 38408066
[TBL] [Abstract][Full Text] [Related]
13. lnc-THRIL and miR-125b relate to disease risk, severity, and imbalance of Th1 cells/Th2 cells in allergic rhinitis.
Song J; Liu D; Yin W
Allergol Immunopathol (Madr); 2022; 50(3):15-23. PubMed ID: 35527652
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers.
Quaglio AEV; Santaella FJ; Rodrigues MAM; Sassaki LY; Di Stasi LC
World J Gastroenterol; 2021 Dec; 27(45):7801-7812. PubMed ID: 34963743
[TBL] [Abstract][Full Text] [Related]
15. Novel MicroRNA Signature to Differentiate Ulcerative Colitis from Crohn Disease: A Genome-Wide Study Using Next Generation Sequencing.
Lin J; Zhang X; Zhao Z; Welker NC; Li Y; Liu Y; Bronner MP
Microrna; 2016; 5(3):222-229. PubMed ID: 27855604
[TBL] [Abstract][Full Text] [Related]
16. Circulating miRNA-16 in inflammatory bowel disease and some clinical correlations - a cohort study in Bulgarian patients.
Atanassova A; Georgieva A
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6310-6315. PubMed ID: 36111932
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer.
Masi L; Capobianco I; Magrì C; Marafini I; Petito V; Scaldaferri F
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887337
[TBL] [Abstract][Full Text] [Related]
18. microRNA in inflammatory bowel disease at a glance.
Alamdari-Palangi V; Vahedi F; Shabaninejad Z; Dokeneheifard S; Movehedpour A; Taheri-Anganeh M; Savardashtaki A
Eur J Gastroenterol Hepatol; 2021 Feb; 32(2):140-148. PubMed ID: 32558695
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease.
Cordes F; Demmig C; Bokemeyer A; Brückner M; Lenze F; Lenz P; Nowacki T; Tepasse P; Schmidt HH; Schmidt MA; Cichon C; Bettenworth D
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00134. PubMed ID: 32352717
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of the multigene analysis test in discriminating between ulcerative colitis and Crohn's disease: a retrospective study.
Janczewska I; Kapraali M; Saboonchi F; Nekzada Q; Wessulv Å; Khoshkar J; Marouf F; Gorsetman J; Risberg D; Lissing M; Wirström G; Sandstedt B
Scand J Gastroenterol; 2012 Feb; 47(2):162-9. PubMed ID: 22229803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
